India, April 13 -- The Government of India has issued a release: Prime Minister Shri Narendra Modi, shared glimpses of his address at the 'Nari Shakti Vandan Sammelan' at Vigyan Bhawan, New Delhi tod... और पढ़ें
India, April 13 -- The Government of India has issued a release: The President of India, Smt Droupadi Murmu graced and addressed the first convocation ceremony of AIIMS Rajkot at Rajkot, Gujarat toda... और पढ़ें
India, April 13 -- The Government of India has issued a release: The President of India, Smt. Droupadi Murmu sends her greetings to fellow-citizens on the eve of the birth anniversary of Dr. B.R. Amb... और पढ़ें
Singapore, April 14 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... और पढ़ें
Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... और पढ़ें
Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... और पढ़ें
Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... और पढ़ें
Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... और पढ़ें
Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... और पढ़ें
Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... और पढ़ें